🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the makers of acetaminophen, alleging the firms withheld potential risks that the drug posed to children's neurological development.

The court filing follows four weeks after Former President Trump publicized an unsubstantiated connection between taking Tylenol - also known as acetaminophen - throughout gestation and autism in offspring.

The attorney general is filing suit against J&J, which once produced the medication, the exclusive pain medication suggested for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he said they "deceived the public by gaining financially from suffering and marketing drugs ignoring the dangers."

Kenvue states there is no credible evidence tying Tylenol to autism.

"These manufacturers misled for generations, knowingly endangering numerous people to increase profits," Paxton, from the Republican party, said.

The company said in a statement that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its official site, the company also stated it had "regularly reviewed the pertinent research and there is lacking reliable evidence that demonstrates a verified association between consuming acetaminophen and autism spectrum disorder."

Associations speaking for physicians and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in Tylenol - is a restricted selection for expectant mothers to manage pain and fever, which can create serious health risks if ignored.

"In multiple decades of investigation on the utilization of paracetamol in pregnancy, zero credible investigations has conclusively proven that the usage of acetaminophen in any stage of pregnancy leads to brain development issues in offspring," the organization commented.

The court filing references latest statements from the previous government in arguing the medication is potentially dangerous.

Recently, the former president caused concern from public health officials when he told expectant mothers to "resist strongly" not to take acetaminophen when sick.

The FDA then published an announcement that doctors should consider limiting the use of Tylenol, while also mentioning that "a proven link" between the drug and autism spectrum disorder in young ones has not been established.

The Health Department head RFK Jr, who manages the Food and Drug Administration, had promised in spring to initiate "comprehensive study program" that would determine the source of autism spectrum disorder in a short period.

But authorities warned that discovering a sole reason of autism - considered by experts to be the consequence of a intricate combination of inherited and surrounding conditions - would be difficult.

Autism is a category of enduring cognitive variation and disability that impacts how individuals experience and interact with the world, and is recognized using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is running for federal office - asserts Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism.

The case aims to force the companies "eliminate any marketing or advertising" that claims Tylenol is secure for expectant mothers.

The court case parallels the complaints of a assembly of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in recently.

A federal judge dismissed the lawsuit, declaring investigations from the parents' expert witnesses was inconclusive.